| Schedule of Computation of Basic and Diluted Net Loss per Share |
The
computation of basic and diluted net loss per share for the three and six months ended June 30, 2026 is as follows (In thousands, except
for share and per share data):
Schedule
of Computation of Basic and Diluted Net Loss per Share
| | |
For
the three months ended June
30, 2026 | |
| Numerator: | |
| | |
| Net loss | |
$ | (65,047 | ) |
| Denominator: | |
| | |
| Weighted average number
of shares of common stock outstanding, basic and diluted | |
| 89,394,753 | |
| Net loss per common
stock, basic and diluted | |
$ | (0.73 | ) |
| | |
For
the six months ended June
30, 2026 | |
| Numerator: | |
| | |
| Net loss | |
$ | (172,806 | ) |
| Denominator: | |
| | |
| Weighted average number
of shares of common stock outstanding, basic and diluted | |
| 86,164,488 | |
| Net loss per common
stock, basic and diluted | |
$ | (2.01 | ) |
|
The
computation of basic and dilutive net loss per share for the period from June 17, 2025 (inception) through December 31, 2025 are as follows:
Schedule
of Computation of Basic and Dilutive Net Loss Per Share
| | |
For
the period from
June
17, 2025
(inception)
through
December
31, 2025 | |
| | |
| |
| Numerator: | |
| | |
| Net loss | |
$ | (28,975,504 | ) |
| | |
| | |
| Denominator: | |
| | |
| Weighted average number
of shares of common stock outstanding, basic and diluted | |
| 73,685,031 | |
| Net loss per common
stock, basic and diluted | |
$ | (0.39 | ) |
|
| Schedule of Computation of Net Loss Per Common Stock |
As
of June 30, 2026, the following potentially dilutive securities were excluded from the computation of diluted net loss per share because
their inclusion would have been anti-dilutive:
Schedule
of Computation of Net Loss Per Common Stock
| | |
For
the three months ended | |
| | |
June
30, 2026 | |
| Warrants | |
| 12,852,500 | |
| RSUs (See Note 11) | |
| 14,342,256 | |
| Convertible Notes | |
| 7,659,240 | |
| Total | |
| 34,853,996 | |
|
As of December 31, 2025, common stock equivalents not included in the computation of net loss per share because their effect would be antidilutive included the following:
Schedule
of Computation of Net Loss Per Common Stock
| | |
| | |
| Warrants (see Note 12) | |
| 12,852,500 | |
| RSUs (see Note 13) | |
| 8,220,000 | |
| Convertible Notes (see Note 8) | |
| 18,071,500 | |
| Total | |
| 39,144,000 | |
|